0001209191-21-035152.txt : 20210521 0001209191-21-035152.hdr.sgml : 20210521 20210521211136 ACCESSION NUMBER: 0001209191-21-035152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210520 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPIEGELMAN DANIEL K CENTRAL INDEX KEY: 0001238403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 21950920 MAIL ADDRESS: STREET 1: MYRIAD GENETICS STREET 2: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-20 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001238403 SPIEGELMAN DANIEL K C/O SPRUCE BIOSCIENCES, INC. 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94014 1 0 0 0 Stock Option (Right to Buy) 15.24 2021-05-20 4 A 0 6667 0.00 A 2031-05-19 Common Stock 6667 6667 D The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2022 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan). /s/ Samir Gharib, Attorney-in-Fact 2021-05-21